// <auto-generated/>
// Contents of: hl7.fhir.r4.core version: 4.0.1
// Minimum TypeScript Version: 3.7
// FHIR ValueSet: http://terminology.hl7.org/ValueSet/v3-ActSubstanceAdminSubstitutionCode|2014-03-26
/**
 * No Description Provided
 */
export const V3ActSubstanceAdminSubstitutionCodeCodes = {
    /**
     * BC: Description:
     *
     *
     *                         Substitution occurred or is permitted between equivalent Brands but not Generics
     *
     *
     *                            Examples:
     *
     *
     *
     *                            Zestril  for Prinivil
     *                            Coumadin for Jantoven
     */
    BrandComposition: "BC",
    /**
     * E: Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
     */
    Equivalent: "E",
    /**
     * EC: Description:
     *
     *
     *                         Substitution occurred or is permitted with another product that is a:
     *
     *
     *                            pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
     *                            pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
     *
     *
     *                            Examples:
     *
     *
     *
     *
     *                               Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
     *
     *                               Pharmaceutical equivalent: Lisonpril for Zestril
     */
    EquivalentComposition: "EC",
    /**
     * F: Description: This substitution was performed or is permitted based on formulary guidelines.
     */
    Formulary: "F",
    /**
     * G: Description: Substitution occurred or is permitted between equivalent Generics but not Brands
     *
     *
     *                            Examples:
     *
     *
     *
     *                            Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
     */
    GenericComposition: "G",
    /**
     * N: No substitution occurred or is permitted.
     */
    None: "N",
    /**
     * TB: Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
     * &gt;
     *                            Examples:
     *
     *
     *
     *                            Zantac for Tagamet
     */
    TherapeuticBrand: "TB",
    /**
     * TE: Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
     *
     *
     *                            Examples:
     *
     *
     *
     *                            ranitidine for Tagamet
     */
    TherapeuticAlternative: "TE",
    /**
     * TG: Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
     * &gt;
     *                            Examples:
     *
     *
     *
     *                            Ranitidine  for cimetidine
     */
    TherapeuticGeneric: "TG",
};
//# sourceMappingURL=data:application/json;base64,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